Screener
Gilead Sciences GILD Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000882095-26-000031
FAQ
- What is Gilead Sciences's contract liabilities?
- Gilead Sciences (GILD) reported contract liabilities of $50M in Q2 2026.
- How has Gilead Sciences's contract liabilities changed year-over-year?
- Gilead Sciences's contract liabilities decreased by 13.8% year-over-year, from $58M to $50M.
- What is the long-term trend for Gilead Sciences's contract liabilities?
- Over 5 years (2020 to 2025), Gilead Sciences's contract liabilities has grown at a -13.1% compound annual growth rate (CAGR), from $97M to $48M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.
Ask your AI about Gilead Sciences's contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude